Cargando…

Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum

Amphotericin B (AmB) in its liposomal form is now considered as either first- or second-line treatment against Leishmania infections in different part of the world. Few cases of AmB resistance have been reported and resistance mechanisms toward AmB are still poorly understood. This paper reports a l...

Descripción completa

Detalles Bibliográficos
Autores principales: Brotherton, Marie-Christine, Bourassa, Sylvie, Légaré, Danielle, Poirier, Guy G., Droit, Arnaud, Ouellette, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095042/
https://www.ncbi.nlm.nih.gov/pubmed/25057462
http://dx.doi.org/10.1016/j.ijpddr.2014.05.002
_version_ 1782325938404458496
author Brotherton, Marie-Christine
Bourassa, Sylvie
Légaré, Danielle
Poirier, Guy G.
Droit, Arnaud
Ouellette, Marc
author_facet Brotherton, Marie-Christine
Bourassa, Sylvie
Légaré, Danielle
Poirier, Guy G.
Droit, Arnaud
Ouellette, Marc
author_sort Brotherton, Marie-Christine
collection PubMed
description Amphotericin B (AmB) in its liposomal form is now considered as either first- or second-line treatment against Leishmania infections in different part of the world. Few cases of AmB resistance have been reported and resistance mechanisms toward AmB are still poorly understood. This paper reports a large-scale comparative proteomic study in the context of AmB resistance. Quantitative proteomics using stable isotope labeling of amino acids in cell culture (SILAC) was used to better characterize cytoplasmic and membrane-enriched (ME) proteomes of the in vitro generated Leishmania infantum AmB resistant mutant AmB1000.1. In total, 97 individual proteins were found as differentially expressed between the mutant and its parental sensitive strain (WT). More than half of these proteins were either metabolic enzymes or involved in transcription or translation processes. Key energetic pathways such as glycolysis and TCA cycle were up-regulated in the mutant. Interestingly, many proteins involved in reactive oxygen species (ROS) scavenging and heat-shock proteins were also up-regulated in the resistant mutant. This work provides a basis for further investigations to understand the roles of proteins differentially expressed in relation with AmB resistance.
format Online
Article
Text
id pubmed-4095042
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-40950422014-07-23 Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum Brotherton, Marie-Christine Bourassa, Sylvie Légaré, Danielle Poirier, Guy G. Droit, Arnaud Ouellette, Marc Int J Parasitol Drugs Drug Resist Brief Report Amphotericin B (AmB) in its liposomal form is now considered as either first- or second-line treatment against Leishmania infections in different part of the world. Few cases of AmB resistance have been reported and resistance mechanisms toward AmB are still poorly understood. This paper reports a large-scale comparative proteomic study in the context of AmB resistance. Quantitative proteomics using stable isotope labeling of amino acids in cell culture (SILAC) was used to better characterize cytoplasmic and membrane-enriched (ME) proteomes of the in vitro generated Leishmania infantum AmB resistant mutant AmB1000.1. In total, 97 individual proteins were found as differentially expressed between the mutant and its parental sensitive strain (WT). More than half of these proteins were either metabolic enzymes or involved in transcription or translation processes. Key energetic pathways such as glycolysis and TCA cycle were up-regulated in the mutant. Interestingly, many proteins involved in reactive oxygen species (ROS) scavenging and heat-shock proteins were also up-regulated in the resistant mutant. This work provides a basis for further investigations to understand the roles of proteins differentially expressed in relation with AmB resistance. Elsevier 2014-05-16 /pmc/articles/PMC4095042/ /pubmed/25057462 http://dx.doi.org/10.1016/j.ijpddr.2014.05.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Brief Report
Brotherton, Marie-Christine
Bourassa, Sylvie
Légaré, Danielle
Poirier, Guy G.
Droit, Arnaud
Ouellette, Marc
Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
title Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
title_full Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
title_fullStr Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
title_full_unstemmed Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
title_short Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum
title_sort quantitative proteomic analysis of amphotericin b resistance in leishmania infantum
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095042/
https://www.ncbi.nlm.nih.gov/pubmed/25057462
http://dx.doi.org/10.1016/j.ijpddr.2014.05.002
work_keys_str_mv AT brothertonmariechristine quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum
AT bourassasylvie quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum
AT legaredanielle quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum
AT poirierguyg quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum
AT droitarnaud quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum
AT ouellettemarc quantitativeproteomicanalysisofamphotericinbresistanceinleishmaniainfantum